FITC Anti-HLA A2 antibody [BB7.2] (ab27728)
Key features and details
- FITC Mouse monoclonal [BB7.2] to HLA A2
- Suitable for: Flow Cyt
- Reacts with: Human
- Conjugation: FITC. Ex: 493nm, Em: 528nm
- Isotype: IgG2b
Overview
-
Product name
FITC Anti-HLA A2 antibody [BB7.2]
See all HLA A2 primary antibodies -
Description
FITC Mouse monoclonal [BB7.2] to HLA A2 -
Host species
Mouse -
Conjugation
FITC. Ex: 493nm, Em: 528nm -
Specificity
Ab27728 recognises the human HLA A2 histocompatability antigen. -
Tested applications
Suitable for: Flow Cytmore details -
Species reactivity
Reacts with: Human -
Immunogen
Papain solubilised HLA A2 (Human).
-
Epitope
The epitope recognised by this antibody has been studied extensively and would appear to include the carboxy terminus of the alpha 2 helix and a turn on one of the underlying beta strands. -
General notes
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Preservative: 0.09% Sodium azide
Constituent: 1% BSA -
Concentration information loading...
-
Purity
Protein G purified -
Purification notes
Ab27728 was purified from tissue culture supernatant, and prepared by affinity chromatography. -
Clonality
Monoclonal -
Clone number
BB7.2 -
Myeloma
NS1 -
Isotype
IgG2b -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
Applications
Our Abpromise guarantee covers the use of ab27728 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Flow Cyt | 1/10. Use 10 µl of the suggested working dilution to label 106 cells or 100µl whole blood.
ab91368 - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.
|
Target
-
Relevance
Involved in the presentation of foreign antigens to the immune system. Dimer of alpha chain and a beta chain (beta-2-microglobulin). Interacts with human herpesvirus 8 MIR1 protein. -
Cellular localization
Membrane; Single-pass type I membrane protein. -
Database links
- Entrez Gene: 3105 Human
- Omim: 142800 Human
- SwissProt: P04439 Human
- Unigene: 181244 Human
-
Alternative names
- Antigen presenting molecule antibody
- HLA A antibody
- HLA A histocompatibility type antibody
see all
Images
Datasheets and documents
References (8)
ab27728 has been referenced in 8 publications.
- Viborg N et al. T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients. Oncoimmunology 8:e1663107 (2019). PubMed: 31741759
- Li D et al. Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies. PLoS One 12:e0176642 (2017). Flow Cyt . PubMed: 28448627
- Kim YH et al. Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99. Oncotarget 7:50535-50547 (2016). PubMed: 27409668
- Straetemans T et al. Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment. Mol Ther 23:396-406 (2015). PubMed: 25363716
- Cheent KS et al. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94. Proc Natl Acad Sci U S A 110:16981-6 (2013). Human . PubMed: 24082146
- Whitfield-Larry F et al. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/?c(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells. Diabetes 60:1726-33 (2011). Flow Cyt . PubMed: 21521873
- Hogan KT & Brown SL Localization and characterization of serologic epitopes on HLA-A2. Hum Immunol 33:185-92 (1992). PubMed: 1377666
- Parham P & Brodsky FM Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 3:277-99 (1981). PubMed: 7035415